N@N

Market Maker Surveillance Report. SPU, ADPT, CBLI, SRNE, PSIX, SSH, Losing Stocks With Lowest Price Friction For Tuesday, Apri

^{Published on 2017-04-18 18:45:37 - WOPRAI}
 

April 18, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 5513 companies with "abnormal" market making, 2442 companies with positive Friction Factors and 3371 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. SkyPeople Fruit Juice Inc (NASDAQ:SPU), Adeptus Health (NYSE:ADPT), Cleveland BioLabs Inc. (NASDAQ:CBLI), Sorrento Therapeutics Inc. (NASDAQ:SRNE), Power Solutions International Inc. (NASDAQ:PSIX), Sunshine Heart Inc. (NASDAQ:SSH). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  SPU     $-0.400   -0.14%    139,180      35.51%    179,951      45.91%    -40,771      -1,019  
  ADPT    $-0.540   -0.27%    1,798,920    39.09%    1,946,707    42.30%    -147,787     -2,737  
  CBLI    $-1.310   -0.27%    2,493,656    33.88%    2,823,107    38.35%    -329,451     -2,515  
  SRNE    $-0.270   -0.15%    1,065,592    30.99%    1,109,640    32.27%    -44,048      -1,631  
  PSIX    $-2.840   -0.31%    560,619      26.77%    770,824      36.81%    -210,205     -740    
  SSH     $-0.290   -0.18%    225,471      23.03%    307,591      31.41%    -82,120      -2,832  

For example, the chart above shows SPU with a dollar loss Tuesday of $-0.40000 and a Friction Factor of -1,019 shares. That means that it only took 1,019 more shares of selling than buying to move SPU lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

SkyPeople Fruit Juice Inc (NASDAQ:SPU) - SkyPeople Fruit Juice, Inc., through its subsidiaries, produces and sells fruit juice concentrates, fruit beverages, and other fruit-related products in the People s Republic of China. The company operates through six segments: Concentrated Apple Juice and Apple Aroma, Concentrated Kiwifruit Juice and Kiwifruit Puree, Concentrated Pear Juice, Fruit Juice Beverages, Fresh Fruits and Vegetables, and Others. It offers fruit juice concentrates, including fruit purees, concentrated fruit purees, and concentrated fruit juices; concentrated apple, pear, and kiwifruit juices; pure fruit juice and fruit cider beverages, including apple juice, pear juice, kiwifruit juice, mulberry juice, kiwifruit cider, mulberry cider, peach juice, and pomegranate juice; and fresh fruits and vegetables, fructose, concentrated fruit and vegetable juices, and turnjujube juice, as well as other by products, such as kiwifruit seeds. The company sells its products directly to end-users; to hotels, supermarkets, and other outlets; and through trade Websites, as well as indirectly through distributors and agents. It also exports its products to Asia, North America, Europe, Russia, and the Middle East. SkyPeople Fruit Juice, Inc. is headquartered in Xi an, the People s Republic of China..

Adeptus Health (NYSE:ADPT) - Adeptus Health Inc. owns and operates a network of independent freestanding emergency rooms in the United States. As of December 31, 2015, it operated 81 facilities located in the Houston, Dallas/Fort Worth, San Antonio, Austin, Colorado Springs, Denver, and Phoenix. The company was founded in 2002 and is based in Lewisville, Texas..

Cleveland BioLabs Inc. (NASDAQ:CBLI) - Cleveland BioLabs, Inc., a biopharmaceutical company, develops novel approaches to activate the immune system and address various medical needs in the United States and the Russian Federation. The company s advanced product candidate is entolimod, a Toll-like receptor 5 (TLR5) agonist that is used to prevent death from acute radiation syndrome, and as an oncology drug. It is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics naturally occurring lipopeptides of Mycoplasma, and activates NF-kB pro-survival and immunoregulatory signaling pathways; and Mobilan, a recombinant non-replicating adenovirus that directs expression of TLR5 and its agonistic ligand. In addition, the company develops CBL0137, a small molecule with a multi-targeted mechanism of action used for the treatment of various types of cancer. Cleveland BioLabs, Inc. has strategic partnerships with The Cleveland Clinic and Roswell Park Cancer Institute. The company was founded in 2003 and is headquartered in Buffalo, New York..

Sorrento Therapeutics Inc. (NASDAQ:SRNE) - Sorrento Therapeutics, Inc., a clinical stage biotechnology company, primarily engages in the discovery and development of therapies focused on oncology and the treatment of chronic cancer pain worldwide. It develops therapeutic products for the treatment of auto-immune, inflammatory, neurodegenerative, and infectious diseases. The company offers resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for the treatment of intractable pain at end-stage disease. Its preclinical human therapeutic antibodies include antibody drug conjugates, bispecific approaches, and T-Cell Receptor, as well as Chimeric Antigen Receptor-T Cell (CAR-T) for adoptive cellular immunotherapy for the treatment of solid and liquid tumors. It is also involved in the development of T-007, an anti-CD38 CAR-T cellular therapy for the treatment of multiple myeloma, as well as for additional potential indications, such as amyloidosis and graft-versus-host disease; and T-009, an anti-CD123 CAR-T cellular therapy for the treatment of acute myelogenous leukemia. The company has license and collaboration agreement with Les Laboratoires Servier for the development, manufacture, and commercialization of products using its human immuno-oncology anti-PD-1 mAb STI-A1110. Sorrento Therapeutics, Inc. was founded in 2006 and is based in San Diego, California..

Power Solutions International Inc. (NASDAQ:PSIX) - .

Sunshine Heart Inc. (NASDAQ:SSH) - .

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net